The impact of postoperative aspirin in patients undergoing Woven EndoBridge: a multicenter, institutional, propensity score-matched analysis

医学 阿司匹林 倾向得分匹配 内科学 人口统计学的 回顾性队列研究 外科 人口学 社会学
作者
Adam A. Dmytriw,Basel Musmar,Hamza Salim,Assala Aslan,Nicole M Cancelliere,Rachel M. McLellan,Oktay Algın,Sherief Ghozy,Mahmoud Dibas,Sovann Lay,Adrien Guenego,Leonardo Renieri,Joseph A. Carnevale,Guillaume Saliou,Panagiotis Mastorakos,Kareem El Naamani,Eimad Shotar,Kévin Premat,Markus Möhlenbruch,Michael Kral
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:: jnis-021082 被引量:8
标识
DOI:10.1136/jnis-2023-021082
摘要

Background The Woven EndoBridge (WEB) device is frequently used for the treatment of intracranial aneurysms. Postoperative management, including the use of aspirin, varies among clinicians and institutions, but its impact on the outcomes of the WEB has not been thoroughly investigated. Methods This was a retrospective, multicenter study involving 30 academic institutions in North America, South America, and Europe. Data from 1492 patients treated with the WEB device were included. Patients were categorized into two groups based on their postoperative use of aspirin (aspirin group: n=1124, non-aspirin group: n=368). Data points included patient demographics, aneurysm characteristics, procedural details, complications, and angiographic and functional outcomes. Propensity score matching (PSM) was applied to balance variables between the two groups. Results Prior to PSM, the aspirin group exhibited significantly higher rates of modified Rankin scale (mRS) mRS 0–1 and mRS 0–2 (89.8% vs 73.4% and 94.1% vs 79.8%, p<0.001), lower rates of mortality (1.6% vs 8.6%, p<0.001), and higher major compaction rates (13.4% vs 7%, p<0.001). Post-PSM, the aspirin group showed significantly higher rates of retreatment (p=0.026) and major compaction (p=0.037) while maintaining its higher rates of good functional outcomes and lower mortality rates. In the multivariable regression, aspirin was associated with higher rates of mRS 0–1 (OR 2.166; 95% CI 1.16 to 4, p=0.016) and mRS 0–2 (OR 2.817; 95% CI 1.36 to 5.88, p=0.005) and lower rates of mortality (OR 0.228; 95% CI 0.06 to 0.83, p=0.025). However, it was associated with higher rates of retreatment (OR 2.471; 95% CI 1.11 to 5.51, p=0.027). Conclusions Aspirin use post-WEB treatment may lead to better functional outcomes and lower mortality but with higher retreatment rates. These insights are crucial for postoperative management after WEB procedures, but further studies are necessary for validation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
kjingknk完成签到 ,获得积分10
刚刚
所所应助青阳采纳,获得10
1秒前
汉堡包应助mywyj采纳,获得10
2秒前
酷波er应助LYY采纳,获得10
2秒前
在水一方应助123采纳,获得10
3秒前
小二郎应助小王采纳,获得30
4秒前
大模型应助无奈的冷雁采纳,获得10
4秒前
4秒前
taotao完成签到,获得积分20
4秒前
小冉发布了新的文献求助10
4秒前
端庄新梅完成签到,获得积分10
5秒前
无极微光应助ZZ采纳,获得20
5秒前
Li发布了新的文献求助10
5秒前
原来完成签到,获得积分20
6秒前
小包完成签到,获得积分10
6秒前
6秒前
NexusExplorer应助正直的西牛采纳,获得10
7秒前
核桃完成签到,获得积分10
8秒前
研友_燥蝉完成签到,获得积分10
8秒前
1号完成签到 ,获得积分10
11秒前
11秒前
李亭如发布了新的文献求助10
12秒前
领导范儿应助YZ采纳,获得10
12秒前
白衣卿相发布了新的文献求助10
14秒前
bkagyin应助小刘同学采纳,获得10
14秒前
量子星尘发布了新的文献求助10
14秒前
15秒前
808bass应助dagongren采纳,获得10
15秒前
传奇3应助小冉采纳,获得10
16秒前
西西完成签到,获得积分10
17秒前
上官若男应助Xorgan采纳,获得10
18秒前
李亭如完成签到,获得积分10
19秒前
云渺发布了新的文献求助10
20秒前
wanci应助cc采纳,获得10
20秒前
miemie66发布了新的文献求助10
21秒前
qw完成签到,获得积分10
21秒前
21秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
nephSAP® Nephrology Self-Assessment Program - Hypertension The American Society of Nephrology 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5632254
求助须知:如何正确求助?哪些是违规求助? 4726532
关于积分的说明 14981567
捐赠科研通 4790212
什么是DOI,文献DOI怎么找? 2558228
邀请新用户注册赠送积分活动 1518633
关于科研通互助平台的介绍 1479071